Casper, Corey

Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial

van Rhee, F., Wong, R. S., Munshi, N., Rossi, J.-F., Ke, X.-Y., Fosså, A., Simpson, D., Capra, M., Liu, T., Hsieh, R. K., et al. (2014) · The Lancet Oncology

Viral-associated cancers and disordersLymphadenopathy Diagnosis and Analysis

Cited by 454

The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman’s disease

Sun, Y., Wang, D., Salvadore, G., Hsu, B., Curran, M., Casper, C., Vermeulen, J., Kent, J. M., Singh, J., Drevets, W. C., et al. (2017) · Brain, Behavior, and Immunity

Rheumatoid Arthritis Research and TherapiesTryptophan and brain disorders

Cited by 100

Analysis of inflammatory and anemia-related biomarkers in a randomized, double-blind, placebo-controlled study of siltuximab (Anti-IL6 Monoclonal Antibody) in patients with multicentric castleman disease

Casper, C., Chaturvedi, S., Munshi, N., Wong, R., Qi, M., Schaffer, M., Bandekar, R., Hall, B., van de Velde, H., Vermeulen, J., et al. (2015) · Clinical Cancer Research

Viral-associated cancers and disordersAutoimmune and Inflammatory Disorders Research

Cited by 97

A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability

Voigt, E. A., Gerhardt, A., Hanson, D., Jennewein, M. F., Battisti, P., Reed, S., Singh, J., Mohamath, R., Bakken, J., Beaver, S., et al. (2022) · npj Vaccines

SARS-CoV-2 and COVID-19 ResearchRNA Interference and Gene Delivery

Cited by 89

Safe living after hematopoietic cell transplantation

Yokoe, D., Casper, C., Dubberke, E., Lee, G., Muñoz, P., Palmore, T., Sepkowitz, K., Young, J.-A., & Donnelly, J. P. (2009) · Bone Marrow Transplantation

Hematopoietic Stem Cell TransplantationNeutropenia and Cancer Infections

Cited by 48